MicroRNA-33b is a Potential Non-Invasive Biomarker for Response to Atorvastatin Treatment in Chilean Subjects With Hypercholesterolemia: A Pilot Study
Evidence accumulated so far indicates that circulating levels of microRNAs (miRNAs) are associated with several pathologies. Therefore, differential expression of extracellular miRNAs exhibits promising potential for screening and diagnosis purposes. We evaluated plasma miRNAs in response to the lip...
Saved in:
Main Authors: | Carmen Gloria Ubilla (Author), Yalena Prado (Author), Jeremy Angulo (Author), Ignacio Obreque (Author), Isis Paez (Author), Nicolás Saavedra (Author), Kathleen Saavedra (Author), Tomás Zambrano (Author), Luis A. Salazar (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Atorvastatin Increases the Expression of Long Non-Coding RNAs ARSR and CHROME in Hypercholesterolemic Patients: A Pilot Study
by: Isis Paez, et al.
Published: (2020) -
Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review
by: Pía Loren, et al.
Published: (2022) -
Altered MicroRNA Expression in the Ischemic-Reperfusion Spinal Cord With Atorvastatin Therapy
by: Jia-Rui Hu, et al.
Published: (2013) -
Delivery of microRNA-33 Antagomirs by Mesoporous Silica Nanoparticles to Ameliorate Lipid Metabolic Disorders
by: Yaoye Tao, et al.
Published: (2020) -
Molecular simulation studies of 3,3'-Diindolylmethane as a Potent MicroRNA-21 Antagonist
by: Md Junaid, et al.
Published: (2017)